Icon Group intends to invest in excess of $65 million to establish these services, enabling Healthscope patients to gain access to the latest radiation technology and treatment techniques within each of the facilities.
Managing Director and CEO of Healthscope, Robert Cooke, made the announcement at the official opening of Knox Private Hospital’s redevelopment in Melbourne on Friday 3 June 2016.
“Our relationship with Icon will enable us to provide comprehensive cancer care services at seven of our hospitals, where radiation oncology services are not currently available. Cancer care is a growing and complex area of medicine often requiring multiple forms of treatment over an extended period of time. We recognise that it can be extremely stressful for patients and their families, however it is often comforting to know that all their treatment needs can be provided within an integrated setting using world’s best practice oncology technology and treatments,” Mr Cooke said.
“Icon Group is one of Australia’s leaders in cancer research and clinical trials which will ensure our patients gain access to new and emerging treatments as they become available. They share our vision for providing quality healthcare for our patients and these shared values will stand us in good stead as we deliver these services.”
